Additional file 4: of The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis

Figure S2. Sensitivity analysis of each included study. (A) Overall cancer; (B) the female group; (C) the male group; (D) non-Hodgkin’s lymphoma; (E) Hodgkin’s lymphoma; (F) leukemia; (G) multiple myeloma; (H) breast cancer; (I) uterus cancer; (J) cervix cancer; (K) ovarian cancer; (L) vagina/vulva cancer; (M) prostate cancer; (N) renal cancer; (O) bladder cancer; (P) esophagus cancer; (Q) gastric cancer; (R) hepatobiliary cancer; (S) pancreatic cancer; (T) colorectal cancer; (U) lung cancer; (V) oropharynx cancer; (W) larynx cancer; (X) cutaneous melanoma; (Y) non-melanoma skin cancer; (Z) brain cancer; (β) thyroid cancer. (DOCX 37.2 kb)